Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 17.19 is 60% above its 3-year average of 10.74, around the middle of its 3-year range (0.00–24.76).
As of the fiscal period ended Tuesday, June 30, 2026. 5.74% above its 12-month average of 16.25.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.19.
QUICK RATIO (ACID-TEST)
17.19
QUICK RATIO (ACID-TEST) AVG TTM
16.25
QUICK RATIO (ACID-TEST) AVG 3Y
13.90
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.74%
CURRENT VS 3Y AVG
+23.65%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+412.33%
vs the sector median at left
BioAge Labs Inc.
Market Cap
$236.82M
Quick Ratio (Acid-Test)
17.19
TTM Avg
16.25
3Y Avg
13.90
5Y Avg
N/A
Market Cap
$237.57M
Quick Ratio (Acid-Test)
5.86
TTM Avg
4.06
3Y Avg
6.91
5Y Avg
7.76
Market Cap
$235.97M
Quick Ratio (Acid-Test)
16.48
TTM Avg
8.13
3Y Avg
6.57
5Y Avg
7.38
Market Cap
$235.66M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.13
3Y Avg
1.14
5Y Avg
1.18
Market Cap
$235.08M
Quick Ratio (Acid-Test)
44.27
TTM Avg
28.93
3Y Avg
23.00
5Y Avg
20.76
Market Cap
$239.01M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.81
3Y Avg
0.76
5Y Avg
0.71
Market Cap
$239.02M
Quick Ratio (Acid-Test)
8.28
TTM Avg
3.73
3Y Avg
7.03
5Y Avg
8.20
Market Cap
$241.34M
Quick Ratio (Acid-Test)
9.97
TTM Avg
9.63
3Y Avg
16.17
5Y Avg
19.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $236.82M | 17.19 | 16.25 | 13.90 | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 5.86 | 4.06 | 6.91 | 7.76 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 16.48 | 8.13 | 6.57 | 7.38 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.35 | 1.13 | 1.14 | 1.18 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 44.27 | 28.93 | 23.00 | 20.76 |
| High Tide Inc. (HITI)vs › | $239.01M | 0.81 | 0.81 | 0.76 | 0.71 |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 8.28 | 3.73 | 7.03 | 8.20 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.35 | 5.50 | 5.94 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 9.97 | 9.63 | 16.17 | 19.97 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 20.30 | 4.91 | 4.89 | 6.73 |
Quick Ratio
17.19
Excludes inventory
Current Ratio
17.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 17.19 |
| 2026-03-31 | 24.76 |
| 2025-12-31 | 14.24 |
| 2025-09-30 | 11.87 |
| 2025-06-30 | 13.21 |
| 2025-03-31 | 13.68 |
| 2024-12-31 | 12.86 |
| 2024-09-30 | 17.63 |
| 2024-06-30 | 12.61 |
| 2024-03-31 | 11.81 |
| 2023-12-31 | 0.44 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
